Nom du produit:5-{[1-(propan-2-yl)-1H-1,2,3-triazol-4-yl]methyl}imidazolidine-2,4-dione
IUPAC Name:5-{[1-(propan-2-yl)-1H-1,2,3-triazol-4-yl]methyl}imidazolidine-2,4-dione
- CAS：1701578-87-1
- Formule moléculaire：C9H13N5O2
- Pureté：95%+
- Numéro de catalogue：CM415915
- Poids moléculaire：223.24
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1701578-87-1
- Formule moléculaire:C9H13N5O2
- Point de fusion:-
- Code SMILES:CC(C)N1C=C(CC2NC(=O)NC2=O)N=N1
- Densité:
- Numéro de catalogue:CM415915
- Poids moléculaire:223.24
- Point d'ébullition:
- N° Mdl:MFCD28124990
- Stockage:
Category Infos
- Triazoles
- Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
- Imidazolidines
- Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.
- imidazolidine supplier
- As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.
Recherche 
+86 21 5895 0110 
